Learning Objectives:
1. To describe the pathophysiologic basis of HFrEF therapies.
2. To identify the indications and contraindications for HFrEF therapies.
3. To understand optimal dosing regimens for HFrEF therapies.
Session date:
11/18/2022 - 12:00pm to 1:00pm CST
Location:
Zoom
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Michelle Kittleson, MD, PhD